Sanofi ADR Valuation
| SNY Stock | USD 54.15 2.00 3.84% |
At this time, the company appears to be undervalued. Sanofi ADR has a current Real Value of $57.69 per share. The regular price of the company is $54.15. Our model measures the value of Sanofi ADR from inspecting the company fundamentals such as Operating Margin of 0.29 %, return on equity of 0.0582, and Shares Outstanding of 2.51 B as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Sanofi ADR's valuation include:
Price Book 1.7222 | Enterprise Value | Enterprise Value Ebitda 15.9496 | Price Sales 2.7492 | Forward PE 12.2549 |
Undervalued
Today
Please note that Sanofi ADR's price fluctuation is very steady at this time. Calculation of the real value of Sanofi ADR is based on 3 months time horizon. Increasing Sanofi ADR's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Sanofi ADR is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sanofi Stock. However, Sanofi ADR's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 54.15 | Real 57.69 | Target 63.06 | Hype 54.46 | Naive 54.61 |
The intrinsic value of Sanofi ADR's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Sanofi ADR's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Sanofi ADR helps investors to forecast how Sanofi stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sanofi ADR more accurately as focusing exclusively on Sanofi ADR's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Sanofi ADR's intrinsic value based on its ongoing forecasts of Sanofi ADR's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Sanofi ADR's closest peers.
Sanofi ADR Cash |
|
Sanofi Valuation Trend
Analysing the historical paterns of Sanofi ADR's enterprise value and its market capitalization is a good way to estimate and gauge the value of Sanofi ADR over time and is usually enough for investors to make rational market timing decisions.
Sanofi ADR Total Value Analysis
Sanofi ADR is at this time estimated to have company total value of 150.89 B with market capitalization of 133.18 B, debt of 18.42 B, and cash on hands of 6.9 B. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Sanofi ADR fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
150.89 B | 133.18 B | 18.42 B | 6.9 B |
Sanofi ADR Investor Information
The company has price-to-book ratio of 1.72. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sanofi ADR has Price/Earnings To Growth (PEG) ratio of 0.96. The entity last dividend was issued on the 9th of May 2024. The firm had 5:1 split on the 30th of September 2013. Based on the analysis of Sanofi ADR's profitability, liquidity, and operating efficiency, Sanofi ADR is performing exceptionally good at this time. It has a great probability to report excellent financial results in March.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.22 | 0.15 |
|
| |||||
| Total Cash From Operating Activities | 7.4 B | 11.8 B |
|
| |||||
| Operating Income | 6 B | 9.1 B |
|
|
Sanofi ADR Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Sanofi ADR has an asset utilization ratio of 36.4 percent. This suggests that the Company is making $0.36 for each dollar of assets. An increasing asset utilization means that Sanofi ADR is more efficient with each dollar of assets it utilizes for everyday operations.Sanofi ADR Ownership Allocation
Sanofi ADR shows a total of 2.51 Billion outstanding shares. About 88.7 % of Sanofi ADR outstanding shares are held by general public with 11.3 % by institutional holders. Please note that on September 6, 2024, Representative John James of US Congress acquired under $15k worth of Sanofi ADR's common stock.Sanofi ADR Profitability Analysis
The company reported the last year's revenue of 46.03 B. Total Income to common stockholders was 5.4 B with profit before taxes, overhead, and interest of 33.48 B.Sanofi ADR Past Distributions to stockholders
About Sanofi ADR Valuation
Our relative valuation model uses a comparative analysis of Sanofi ADR. We calculate exposure to Sanofi ADR's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Sanofi ADR's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 36.6 B | 22 B | |
| Pretax Profit Margin | 0.18 | 0.21 | |
| Operating Profit Margin | 0.15 | 0.22 | |
| Net Profit Margin | 0.11 | 0.12 | |
| Gross Profit Margin | 0.69 | 0.79 |
A single share of Sanofi ADR represents a small ownership stake in the entity. As a stockholder of Sanofi, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Sanofi ADR Dividends Analysis For Valuation
Please note that Sanofi ADR has scaled down on payment of dividends at this time. Price Earnings Ratio is likely to rise to 24.50 in 2025, whereas Retained Earnings are likely to drop slightly above 73.7 B in 2025.
There are various types of dividends Sanofi ADR can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Sanofi shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Sanofi ADR directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Sanofi pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Sanofi ADR by the value of the dividends paid out.
Sanofi ADR Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 1.3 B | |
| Quarterly Earnings Growth Y O Y | 0.115 | |
| Forward Price Earnings | 12.2549 |
Sanofi ADR Current Valuation Indicators
Valuation refers to the process of determining the present value of Sanofi ADR and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Sanofi we look at many different elements of the entity such as Sanofi's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Sanofi ADR, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Sanofi ADR's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Sanofi ADR's worth.Additional Tools for Sanofi Stock Analysis
When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.